IPSEN LIMITED
Company Information
- Company Number
- 06751069
- Registered Address
- 5th Floor The Point, 37 North Wharf Road, London, United Kingdom, W2 1AF
- Status
- Active
- Employee Count
- 101
- Turnover
- £107,867,000
- EBITDA
- £2,894,000
Additional Details
- Website
- https://www.ipsen.com/
- Company Type
- Private limited Company
- Incorporated On
- 17 November 2008
- Nature of Business
- 46460 - Wholesale of pharmaceutical goods
- Industries
- Life Sciences And Medical Technology
- Region
- London
Time to Pay
Payment Timeline
Payment Features
Payment Score History
Performance Reports History
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jan 2025 - 30 Jun 2025 | 30 Jul 2025 | 30 | 62% | 35% | 3% | 24% |
| 01 Jul 2023 - 31 Dec 2023 | 30 Jan 2024 | 24 | 81% | 19% | 1% | 22% |
| 01 Jan 2023 - 30 Jun 2023 | 31 Jul 2023 | 25 | 79% | 16% | 5% | 26% |
| 01 Jul 2022 - 31 Dec 2022 | 25 Jan 2023 | 27 | 76% | 21% | 3% | 26% |
| 01 Jan 2022 - 30 Jun 2022 | 21 Jul 2022 | 27 | 76% | 17% | 7% | 24% |
| 01 Jul 2021 - 31 Dec 2021 | 25 Jan 2022 | 26 | 78% | 19% | 3% | 17% |
| 01 Jan 2021 - 30 Jun 2021 | 29 Jul 2021 | 27 | 79% | 17% | 4% | 21% |
| 01 Jul 2019 - 31 Dec 2019 | 28 Jan 2020 | 24 | 81% | 12% | 7% | 23% |
| 01 Jan 2019 - 30 Jun 2019 | 26 Jul 2019 | 30 | 67% | 26% | 6% | 25% |
| 01 Jul 2018 - 31 Dec 2018 | 25 Jan 2019 | 30 | 65% | 30% | 5% | 35% |
Payment Time Trends
Payment Distribution Trends
Invoice Payment Practices
This information is as reported by the business, and responses are in their own words.
Payment Terms
Standard payment terms
Standard payment terms: 30 days from the invoices date for third party vendors 45days end of the month for intercompany transactions
Were there any changes to the standard payment terms in the reporting period?
No information available
Any other information about payment terms
No additional information
Maximum contractual payment period agreed
90
Dispute Resolution Process
In case of any discrepancy between goods received and invoice receipt - person who made an order is responsible for contacting the vendor and understand the difference There is a generic email address and direct phone number available for all vendors where all payment related questions can be routed Terms and conditions are attached to the copy of the Purchase Order that is sent to vendors
Other Payment Information
Has this business signed up to a code of conduct or standards on payment practices?
For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.
❌
Does this business offer e-invoicing in relation to qualifying contracts?
This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.
❌
Does this business offer supply chain finance?
This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.
❌
Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?
❌
During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?
No information available
Company Summary
IPSEN LIMITED is a global biopharmaceutical company that specializes in developing and manufacturing innovative medicines for patients with serious and rare diseases. The company was founded in 1929 and is headquartered in Paris, France, with a registered office in Slough, UK.
The company's sustainability program is focused on four key areas: access to healthcare, environmental responsibility, ethical business practices, and employee well-being. IPSEN is dedicated to providing affordable and sustainable access to its medicines for patients worldwide, while also minimizing its environmental impact through responsible manufacturing and waste management practices. The company also upholds strict ethical standards in its business operations and prioritizes the well-being and development of its employees.
IPSEN's products and services cover a wide range of therapeutic areas, including oncology, neuroscience, and rare diseases. The company's portfolio includes treatments for conditions such as pancreatic cancer, neuroendocrine tumors, and spasticity. IPSEN also offers support services for patients and healthcare professionals, such as disease education and financial assistance programs.
The key people at IPSEN LIMITED include CEO David Loew, who has been in the role since 2019 and has over 25 years of experience in the pharmaceutical industry. Other key executives and members of the board of directors bring a wealth of expertise from various backgrounds, including research and development, finance, and marketing.
For more information on IPSEN and its products and services, visit their website at www.ipsen.com. The company's registered office address in the UK is 190 Bath Road, Slough, Berkshire, SL1 3XE.
